Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1007712 on May 8, 2008

Published online before print May 8, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1007712v1
84/2/460    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mnasria, K.
Right arrow Articles by Baron, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mnasria, K.
Right arrow Articles by Baron, C.
(Journal of Leukocyte Biology. 2008;84:460-467.)
© 2008 by Society for Leukocyte Biology

Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells

K. Mnasria*,1,2, C. Lagaraine*,1, F. Velge-Roussel*,{dagger}, R. Oueslati{ddagger}, Y. Lebranchu*,§ and C. Baron*,§,3

* JE 2448, "Cellules Dendritiques et Greffes," Faculté de Medicine, Université François Rabelais, Tours, France;
{dagger} UFR des Sciences Pharmaceutiques, Tours, France;
{ddagger} UR Immuno-Microbiologie Environnementale et Cancérogenèse, Faculté des Sciences de Bizerte, and Banque de Tissus, Hôpital Militaire de Tunis, Tunis, Tunisia; and
§ Department of Immunology and Nephrology, Bretonneau Hospital, Tours, France

3 Correspondence: Faculté de Médecine, Université François Rabelais, Equipe JE 2448 "Cellules Dendritiques et Greffe," 10 Bd Tonnelle, 37032 Tours Cedex, France. E-mail: baron{at}med.univ-tours.fr

Anti-CD25 monoclonal antibodies are widely used in clinical transplantation to prevent acute allograft rejection. Although their effects on T lymphocytes have been extensively studied, their impact on human dendritic cells (DC) has never been reported. Furthermore, the role of the IL-2 in DC functions has not yet been fully elucidated. In this study, we confirm that the stimulation of human monocyte-derived DC with LPS strongly induced the expression of CD25 and that LPS-matured DC also expressed the β and {gamma} chain of the IL-2R. We also showed that adding anti-CD25 monoclonal antibodies to LPS induced a decrease in IL-12, IL-1, TNF-{alpha}, IL-6, and IFN-{gamma} production and an increase in IL-10 synthesis by DC compared with stimulation with LPS alone. Furthermore, we showed that these modifications diminished the T helper priming ability of DC and polarized the alloimmune response toward TH2. In contrast, humanized anti-CD25 monoclonal antibodies did not affect the up-regulation of CD86, CD80, CD83, HLADR, or CD40 induced upon LPS stimulation. Taken together, this study discloses some previously unrecognized effects of anti-CD25 monoclonal antibodies on DC that may contribute to their clinical efficacy. In addition, this study also shed some light on the role of the IL-2 in human DC activation.

Key Words: interleukin-2 • DC maturationDC activation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Leukocyte Biology.